The U.S. Department of Commerce has launched a national security investigation into imports of pharmaceuticals and ingredients under Section 232 of the Trade Expansion Act. They’re seeking public input on supply chain risks, foreign dependence, trade practices, and domestic production capacity.

Deadline: Submit comments by May 7, 2025
Submit here: www.regulations.gov (ID: BIS-2025-0022)
Details: https://federalregister.gov/d/2025-06587

Concernfaggin to the max.

"...despite CEO panic, employment remains unquestionably strong."

https://www.zerohedge.com/markets/wtf-are-ceos-waiting-jobless-claims-refuse-buckel-recession-narrative

LIFT.

Good times 👍

➡️ ↘️↙️↖️↕️↔️↪️↩️⤴️⤵️🔀🔁🔂🔄🔃

Virginia didn't kill herself.

N I G H T S H I F T 🌙